- Home
- SHFS vs INKT Comparison
SHFS vs INKT Comparison
Compare SHFS & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHFS
- INKT
- Stock Information
- Founded
- SHFS 2015
- INKT 2017
- Country
- SHFS United States
- INKT United States
- Employees
- SHFS N/A
- INKT N/A
- Industry
- SHFS Finance: Consumer Services
- INKT Medicinal Chemicals and Botanical Products
- Sector
- SHFS Finance
- INKT Health Care
- Exchange
- SHFS Nasdaq
- INKT Nasdaq
- Market Cap
- SHFS 25.6M
- INKT 30.6M
- IPO Year
- SHFS N/A
- INKT 2021
- Fundamental
- Price
- SHFS $0.49
- INKT $0.70
- Analyst Decision
- SHFS
- INKT Strong Buy
- Analyst Count
- SHFS 0
- INKT 1
- Target Price
- SHFS N/A
- INKT $9.00
- AVG Volume (30 Days)
- SHFS 51.1K
- INKT 50.8K
- Earning Date
- SHFS 11-12-2024
- INKT 11-07-2024
- Dividend Yield
- SHFS N/A
- INKT N/A
- EPS Growth
- SHFS N/A
- INKT N/A
- EPS
- SHFS 0.08
- INKT N/A
- Revenue
- SHFS $16,719,536.00
- INKT N/A
- Revenue This Year
- SHFS N/A
- INKT N/A
- Revenue Next Year
- SHFS N/A
- INKT N/A
- P/E Ratio
- SHFS $5.56
- INKT N/A
- Revenue Growth
- SHFS 34.73
- INKT N/A
- 52 Week Low
- SHFS $0.44
- INKT $0.57
- 52 Week High
- SHFS $1.55
- INKT $1.90
- Technical
- Relative Strength Index (RSI)
- SHFS 51.15
- INKT 46.88
- Support Level
- SHFS $0.46
- INKT $0.65
- Resistance Level
- SHFS $0.51
- INKT $0.72
- Average True Range (ATR)
- SHFS 0.03
- INKT 0.05
- MACD
- SHFS 0.00
- INKT 0.00
- Stochastic Oscillator
- SHFS 80.61
- INKT 71.61
About SHFS SHF Holdings Inc.
SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring among others.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.